PATENT CLAIM ANALYSIS

Application Number: 15745437
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "218000"]

Abstract:
The present invention relates quinazolinone compounds of Formula (I), as well as their preparation and uses, and further relates pharmaceutical compositions comprising these compounds and their uses; wherein the compounds or pharmaceutical compositions disclosed herein can be used for antagonizing the orexin receptor. The present invention also relates to uses of the compounds or pharmaceutical compositions in treating or preventing neurological and psychiatric disorders and diseases of the central nervous system in mammals, especially in humans.

Claim (Index 22):
A method for selectively antagonizing orexin receptor in a mammal or a patient comprising administering to the mammal or patient a therapeutically effective amount of the compound of  claim 1 .

Metadata:
- Claim Count in Document: 17.0
- Percentile: 86.0
- Lexical Diversity: 1.61538
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16326189', '15314932', '16327335', '12576375', '13587936']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7641523014163053
- 35 USC 102 Novelty (BERT): 0.5319920984825653
- Combined Prediction Score: 0.7409362811229313
- Mean Citation Score: 328.7722179999999
- Max Citation Score: 336.8668
- Similarity Product: 220.28985936841968

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test